GSK3732394
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3732394, covering 2021-04-12 to 2021-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study [Phase 1]